For instance, in a NAFLD model, high levels of Lcn-2 in the blood increased the expression of the Lcn-2 receptor (24p3R) on brain cells and stimulated the release of HMGB1. This evidence concerns the gene LCN2 and metabolic dysfunction-associated steatotic liver disease.